Matthew M Hsieh
Overview
Explore the profile of Matthew M Hsieh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1986
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inam Z, Jeffries N, Link M, Coles W, Pollack P, Luckett C, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 40010689
Nonmyeloablative (NMA) conditioning is being used increasingly with success in matched related donor (MRD) and alternative donor allogeneic hematopoietic cell transplantation (allo-HCT) in individuals with sickle cell disease (SCD). Advantages...
2.
Ali M, Limerick E, Hsieh M, Upadhyaya K, Xu X, Phang O, et al.
Am J Hematol
. 2025 Feb;
PMID: 39912461
No abstract available.
3.
Ali M, Limerick E, Hsieh M, Upadhyaya K, Xu X, Phang O, et al.
medRxiv
. 2025 Jan;
PMID: 39867410
Non-myeloablative hematopoietic cell transplantation (HCT) is a curative option for individuals with sickle cell disease (SCD). Our traditional goal with this approach has been to achieve a state of mixed...
4.
Ruhl A, Limerick E, Barochia A, Fitzhugh C, Hsieh M
Ann Am Thorac Soc
. 2025 Jan;
PMID: 39836961
No abstract available.
5.
Queen J, Limerick E, Jeffries N, Hsieh M, Shamburek R, Fitzhugh C
Transplant Cell Ther
. 2024 Dec;
31(2):82.e1-82.e8.
PMID: 39701291
Individuals with sickle cell disease (SCD) have a unique type of dyslipidemia characterized by low total cholesterol (TC), low low-density lipoprotein cholesterol (LDL-c), low high-density lipoprotein cholesterol (HDL-c), and normal...
6.
Ruhl A, Hsieh M, Stuart E
JAMA Intern Med
. 2024 Sep;
184(11):1372-1373.
PMID: 39250146
No abstract available.
7.
Ruhl A, Shalhoub R, Jeffries N, Limerick E, Leonard A, Barochia A, et al.
Ann Am Thorac Soc
. 2024 Aug;
21(10):1398-1406.
PMID: 39189784
Sickle cell disease (SCD) is a monogenetic condition with recurring vasoocclusive events causing lifelong pulmonary morbidity and mortality. There is increasing access to curative therapies, such as hematopoietic cell transplant...
8.
Leonard A, Furstenau D, Inam Z, Luckett C, Chu R, Demirci S, et al.
Blood Adv
. 2024 Jan;
8(7):1806-1816.
PMID: 38181784
Stable, mixed-donor-recipient chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for patients with sickle cell disease (SCD) is sufficient for phenotypic disease reversal, and results from differences in donor/recipient-red blood...
9.
Mandava M, Lew J, Tisdale J, Limerick E, Fitzhugh C, Hsieh M
J Endocr Soc
. 2023 Nov;
7(12):bvad134.
PMID: 37953902
Purpose: To determine the rate and clinical characteristics associated with abnormal thyroid and adrenal function in recipients of nonmyeloablative hematopoietic cell transplantation (HCT) for sickle cell disease (SCD) and beta-thalassemia....
10.
Metaferia B, Cellmer T, Dunkelberger E, Li Q, Henry E, Hofrichter J, et al.
Proc Natl Acad Sci U S A
. 2022 Sep;
119(40):e2210779119.
PMID: 36161945
Stem cell transplantation and genetic therapies offer potential cures for patients with sickle cell disease (SCD), but these options require advanced medical facilities and are expensive. Consequently, these treatments will...